Strategic Global Advisors’s ResMed RMD Stock Holding History

Strategic Global Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.29M	Sell	19,115 -470	-2%	-$117K	0.69%	48
2025 Q4	$4.72M	Sell	19,585 -440	-2%	-$113K	0.73%	49
2025 Q3	$5.48M	Sell	20,025 -340	-2%	-$92.9K	0.83%	41
2025 Q2	$5.25M	Buy	20,365 +1,218	+6%	+$291K	0.86%	41
2025 Q1	$4.29M	Sell	19,147 -690	-3%	-$161K	0.85%	40
2024 Q4	$4.54M	Buy	19,837 +6,818	+52%	+$1.64M	0.83%	37
2024 Q3	$3.18M	Buy	+13,019	New	+$2.91M	0.63%	54
2021 Q1	–	Sell	-1,004	Closed	-$213K	–	179
2020 Q4	$213K	Buy	+1,004	New	+$200K	0.04%	154

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Strategic Global Advisors's RMD Position: Q1 2026 in Review

Strategic Global Advisors reduced its ResMed (RMD) stake by 2.4% in Q1 2026, selling an estimated $117K and leaving 19,115 shares worth $4.29M. The position accounts for 0.69% of the portfolio, ranked #48.

Strategic Global Advisors first reported a position in RMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $5.48M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Strategic Global Advisors held 19,115 shares of ResMed worth $4.29M as of Q1 2026.
Strategic Global Advisors sold 470 ResMed shares in Q1 2026, an estimated $117K.
ResMed made up 0.69% of Strategic Global Advisors's portfolio in Q1 2026, its #48 holding.
Strategic Global Advisors first reported a position in ResMed in Q4 2020 and has held it in 8 quarters since.
Strategic Global Advisors's ResMed position peaked at $5.48M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Strategic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.